The telemonitoring of Patients with Chronic Obstructive Pulmonary Disease (COPD) aims to promote the continuous monitoring of patients in order to improve their quality of life and observe health gains, using a patient-centered approach and the establishment of community partnerships.
Chronic obstructive pulmonary disease is an obstructive lung disease characterized by chronic and only partially reversible airway limitation and destruction of lung tissue. It originates from a significant inflammatory response to the inhalation of irritants such as, for example, tobacco. It is a progressive disease that has no cure, since the lesions it causes in the lungs do not regress and current treatments are only able to delay the loss of function. This progression also contributes to a lower tolerance to effort by the patient, which leads to a progressive withdrawal from normal activity.
COPD is a multisystemic disease, in which comorbidities play an important role.
The leading cause of COPD is smoking.
Frequent inhalation of certain types of environmental or occupational pollution can also cause inflammation of the respiratory tract, weakening the mucosa and contributing to the onset of the disease.
The hereditary deficiency of a protein called alpha 1-antitrypsin may also be associated with the occurrence of COPD.
In the case of COPD, the monitored parameters (though these may vary depending on the patient), include:
According to Sociedade Portuguesa de Pneumologia (SPP), it is estimated that in Portugal:
4 million days
5th cause of death